InvestorsHub Logo
Followers 106
Posts 17038
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Tuesday, 04/09/2024 9:11:42 AM

Tuesday, April 09, 2024 9:11:42 AM

Post# of 76
Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVKD News